(2026). Inhibition of HER2 signaling and breast cancer cell growth with a novel antibody targeting HER2 ECD III/IV. PLOS ONE.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Inhibition of HER2 Signaling and Breast Cancer Cell Growth with a Novel Antibody Targeting HER2 ECD III/IV."
PLOS ONE 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Inhibition of HER2 Signaling and Breast Cancer Cell Growth with a Novel Antibody Targeting HER2 ECD III/IV."
PLOS ONE, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.